Indications
VacPertagen is indicated for: - booster immunisation against pertussis of individuals 12 years of age and older,- passive protection against pertussis in early infancy following maternal immunisation during pregnancy.
Composition
- Active substance
- recombinant pertussis toxin, filamentous haemagglutinin
- International name (INN)
- pertussis vaccine (recombinant, acellular, component, adsorbed)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- VacPertagen
- Active substance
- recombinant pertussis toxin, filamentous haemagglutinin
- ATC code
- J07AJ02
- Therapeutic area